{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T03:52:27Z","timestamp":1793418747344,"version":"4.5.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T00:00:00Z","timestamp":1740960000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["ajp.amjpathol.org","clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.ajpath.2025.02.004","type":"journal-article","created":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T10:28:25Z","timestamp":1741256905000},"page":"1158-1171","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["C5aR1 Promotes Invasion, Metastasis, and Poor Prognosis in Cutaneous Squamous Cell Carcinoma"],"prefix":"10.1016","volume":"195","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0939-5323","authenticated-orcid":false,"given":"Lauri","family":"Heiskanen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6743-6736","authenticated-orcid":false,"given":"Liisa","family":"Nissinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1709-8633","authenticated-orcid":false,"given":"Elina","family":"Siljam\u00e4ki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaakko S.","family":"Knuutila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9652-7373","authenticated-orcid":false,"given":"Teijo","family":"Pellinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markku","family":"Kallajoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyrki","family":"Heino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilvi","family":"Riihil\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2421-9368","authenticated-orcid":false,"given":"Veli-Matti","family":"K\u00e4h\u00e4ri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpath.2025.02.004_bib1","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1056\/NEJMra1708701","article-title":"Update on keratinocyte carcinomas","volume":"379","author":"Nehal","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpath.2025.02.004_bib2","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1001\/jamadermatol.2018.4219","article-title":"Nationwide incidence of metastatic cutaneous squamous cell carcinoma in England","volume":"155","author":"Venables","year":"2019","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ajpath.2025.02.004_bib3","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/bjd.17873","article-title":"Epidemiology of basal and cutaneous squamous cell carcinoma in the U.K. 2013-15: a cohort study","volume":"181","author":"Venables","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ajpath.2025.02.004_bib4","doi-asserted-by":"crossref","DOI":"10.2340\/actadv.v104.40990","article-title":"Clinical risk factors for cutaneous squamous cell carcinoma in patients with actinic keratosis or cutaneous squamous cell carcinoma in situ: a retrospective double-cohort study","volume":"104","author":"Knuutila","year":"2024","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.ajpath.2025.02.004_bib5","doi-asserted-by":"crossref","DOI":"10.2340\/00015555-3628","article-title":"Risk factors and prognosis for metastatic cutaneous squamous cell carcinoma: A cohort study","volume":"100","author":"Knuutila","year":"2020","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.ajpath.2025.02.004_bib6","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1158\/1078-0432.CCR-18-1122","article-title":"Keratinocyte carcinomas: current concepts and future research priorities","volume":"25","author":"Nagarajan","year":"2019","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ajpath.2025.02.004_bib7","article-title":"European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma. Part 1: diagnostics and prevention\u2014update 2023","volume":"193","author":"Stratigos","year":"2023","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ajpath.2025.02.004_bib8","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/978-1-4614-5915-6_11","article-title":"The role of complement in tumor growth","volume":"772","author":"Pio","year":"2014","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.ajpath.2025.02.004_bib9","doi-asserted-by":"crossref","first-page":"3550","DOI":"10.3390\/ijms20143550","article-title":"Complement system in cutaneous squamous cell carcinoma","volume":"20","author":"Riihil\u00e4","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ajpath.2025.02.004_bib10","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1158\/2326-6066.CIR-23-0399","article-title":"The yin yang of complement and cancer","volume":"11","author":"Meri","year":"2023","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.ajpath.2025.02.004_bib11","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/jid.2013.346","article-title":"Complement factor H: a biomarker for progression of cutaneous squamous cell carcinoma","volume":"134","author":"Riihil\u00e4","year":"2014","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ajpath.2025.02.004_bib12","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/jid.2014.376","article-title":"Complement factor I promotes progression of cutaneous squamous cell carcinoma","volume":"135","author":"Riihil\u00e4","year":"2015","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ajpath.2025.02.004_bib13","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.ajpath.2017.01.006","article-title":"Complement component C3 and complement factor B promote growth of cutaneous squamous cell carcinoma","volume":"187","author":"Riihil\u00e4","year":"2017","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2025.02.004_bib14","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1111\/bjd.18095","article-title":"Tumour-cell-derived complement components C1r and C1s promote growth of cutaneous squamous cell carcinoma","volume":"182","author":"Riihil\u00e4","year":"2020","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ajpath.2025.02.004_bib15","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1111\/exd.14349","article-title":"Complement factor I upregulates expression of matrix metalloproteinase-13 and -2 and promotes invasion of cutaneous squamous carcinoma cells","volume":"30","author":"Rahmati Nezhad","year":"2021","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.ajpath.2025.02.004_bib16","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/j.jid.2021.10.008","article-title":"C1r upregulates production of matrix metalloproteinase-13 and promotes invasion of cutaneous squamous cell carcinoma","volume":"142","author":"Viiklepp","year":"2022","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ajpath.2025.02.004_bib17","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3390\/cancers14020305","article-title":"Complement factor D is a novel biomarker and putative therapeutic target in cutaneous squamous cell carcinoma","volume":"14","author":"Rahmati Nezhad","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ajpath.2025.02.004_bib18","doi-asserted-by":"crossref","first-page":"236","DOI":"10.2174\/187152809788681038","article-title":"The role of anaphylatoxins C3a and C5a in regulating innate and adaptive immune responses","volume":"8","author":"Peng","year":"2009","journal-title":"Inflamm Allergy Drug Targets"},{"key":"10.1016\/j.ajpath.2025.02.004_bib19","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/sj.icb.7100166","article-title":"Receptors for complement C5a. The importance of C5aR and the enigmatic role of C5L2","volume":"86","author":"Lee","year":"2008","journal-title":"Immunol Cel Biol"},{"key":"10.1016\/j.ajpath.2025.02.004_bib20","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s00109-009-0442-7","article-title":"Functions of C5a receptors","volume":"87","author":"Ward","year":"2009","journal-title":"J Mol Med (Berl)"},{"key":"10.1016\/j.ajpath.2025.02.004_bib21","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.4049\/jimmunol.169.6.3223","article-title":"Complement-induced impairment of innate immunity during sepsis","volume":"169","author":"Huber-Lang","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.ajpath.2025.02.004_bib22","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1080\/08916930600739456","article-title":"Complement in lung disease","volume":"39","author":"Sarma","year":"2006","journal-title":"Autoimmunity"},{"key":"10.1016\/j.ajpath.2025.02.004_bib23","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/art.1780310508","article-title":"Increased levels of plasma anaphylatoxins in systemic lupus erythematosus predict flares of the disease and may elicit vascular injury in lupus cerebritis","volume":"31","author":"Hopkins","year":"1988","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ajpath.2025.02.004_bib24","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.lungcan.2013.04.020","article-title":"Overexpression of CD88 predicts poor prognosis in non-small-cell lung cancer","volume":"81","author":"Gu","year":"2013","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ajpath.2025.02.004_bib25","doi-asserted-by":"crossref","first-page":"3995","DOI":"10.3892\/ol.2016.5137","article-title":"C5a receptor expression is associated with poor prognosis in urothelial cell carcinoma patients treated with radical cystectomy or nephroureterectomy","volume":"12","author":"Wada","year":"2016","journal-title":"Oncol Lett"},{"key":"10.1016\/j.ajpath.2025.02.004_bib26","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.3892\/or.2015.3800","article-title":"C5aR is frequently expressed in metastatic renal cell carcinoma and plays a crucial role in cell invasion via the ERK and PI3 kinase pathways","volume":"33","author":"Maeda","year":"2015","journal-title":"Oncol Rep"},{"key":"10.1016\/j.ajpath.2025.02.004_bib27","doi-asserted-by":"crossref","first-page":"80925","DOI":"10.18632\/oncotarget.13108","article-title":"Enrichment of C5a-C5aR axis predicts poor postoperative prognosis of patients with clear cell renal cell carcinoma","volume":"7","author":"Xi","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ajpath.2025.02.004_bib28","doi-asserted-by":"crossref","first-page":"84798","DOI":"10.18632\/oncotarget.12656","article-title":"C5a receptor (CD88) promotes motility and invasiveness of gastric cancer by activating RhoA","volume":"7","author":"Kaida","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ajpath.2025.02.004_bib29","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s12032-016-0834-9","article-title":"Expression of the anaphylatoxin C5a receptor in gastric cancer: implications for vascular invasion and patient outcomes","volume":"33","author":"Nitta","year":"2016","journal-title":"Med Oncol"},{"key":"10.1016\/j.ajpath.2025.02.004_bib30","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.yexmp.2015.10.001","article-title":"C5a receptor enhances hepatocellular carcinoma cell invasiveness via activating ERK1\/2-mediated epithelial-mesenchymal transition","volume":"100","author":"Hu","year":"2016","journal-title":"Exp Mol Pathol"},{"key":"10.1016\/j.ajpath.2025.02.004_bib31","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/pros.24090","article-title":"Prostate cancer C5a receptor expression and augmentation of cancer cell proliferation, invasion, and PD-L1 expression by C5a","volume":"81","author":"Imamura","year":"2021","journal-title":"Prostate"},{"key":"10.1016\/j.ajpath.2025.02.004_bib32","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1007\/s12282-015-0654-3","article-title":"Influence of the C5a-C5a receptor system on breast cancer progression and patient prognosis","volume":"23","author":"Imamura","year":"2016","journal-title":"Breast Cancer"},{"key":"10.1016\/j.ajpath.2025.02.004_bib33","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1186\/s12885-021-08883-5","article-title":"Clinicopathological features and prognostic significance of C5aR in human solid tumors: a meta-analysis","volume":"21","author":"Wang","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ajpath.2025.02.004_bib34","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.semcdb.2017.11.023","article-title":"Complement anaphylatoxins C3a and C5a: emerging roles in cancer progression and treatment","volume":"85","author":"Ajona","year":"2019","journal-title":"Semin Cel Dev Biol"},{"key":"10.1016\/j.ajpath.2025.02.004_bib35","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/s41568-019-0210-0","article-title":"Context-dependent roles of complement in cancer","volume":"19","author":"Roumenina","year":"2019","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ajpath.2025.02.004_bib36","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/exd.13109","article-title":"Dasatinib promotes apoptosis of cutaneous squamous carcinoma cells by regulating activation of ERK1\/2","volume":"26","author":"Farshchian","year":"2017","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.ajpath.2025.02.004_bib37","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-64088-3","article-title":"C1s targeting antibodies inhibit the growth of cutaneous squamous carcinoma cells","volume":"14","author":"Nissinen","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.ajpath.2025.02.004_bib38","first-page":"2840","article-title":"c-Ha-ras oncogene expression in immortalized human keratinocytes (HaCaT) alters growth potential in vivo but lacks correlation with malignancy","volume":"50","author":"Boukamp","year":"1990","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2025.02.004_bib39","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.matbio.2019.09.001","article-title":"H-Ras activation and fibroblast-induced TGF-[beta] signaling promote laminin-332 accumulation and invasion in cutaneous squamous cell carcinoma","volume":"87","author":"Siljam\u00e4ki","year":"2020","journal-title":"Matrix Biol"},{"key":"10.1016\/j.ajpath.2025.02.004_bib40","doi-asserted-by":"crossref","first-page":"3633","DOI":"10.1038\/s41388-023-02863-8","article-title":"Inhibition of TGF-[beta] signaling, invasion, and growth of cutaneous squamous cell carcinoma by PLX8394","volume":"42","author":"Siljam\u00e4ki","year":"2023","journal-title":"Oncogene"},{"key":"10.1016\/j.ajpath.2025.02.004_bib41","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1038\/s41592-021-01291-4","article-title":"MISpheroID: a knowledgebase and transparency tool for minimum information in spheroid identity","volume":"18","author":"Peirsman","year":"2021","journal-title":"Nat Methods"},{"key":"10.1016\/j.ajpath.2025.02.004_bib42","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat Methods"},{"key":"10.1016\/j.ajpath.2025.02.004_bib43","doi-asserted-by":"crossref","DOI":"10.1126\/science.aan2507","article-title":"A Pathology Atlas Of The Human Cancer Transcriptome","volume":"357","author":"Uhlen","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.ajpath.2025.02.004_bib44","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/ng.2764","article-title":": The Cancer Genome Atlas Pan-Cancer analysis project","volume":"45","author":"Weinstein","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.ajpath.2025.02.004_bib45","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1002\/ijc.34957","article-title":"Cancer-associated fibroblast activation predicts progression, metastasis, and prognosis of cutaneous squamous cell carcinoma","volume":"155","author":"Knuutila","year":"2024","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ajpath.2025.02.004_bib46","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1158\/1078-0432.CCR-12-1204","article-title":"Enhancement of human cancer cell motility and invasiveness by anaphylatoxin C5a via aberrantly expressed C5a receptor (CD88)","volume":"19","author":"Nitta","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ajpath.2025.02.004_bib47","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1158\/2159-8290.CD-16-1184","article-title":"A combined PD-1\/C5a blockade synergistically protects against lung cancer growth and metastasis","volume":"7","author":"Ajona","year":"2017","journal-title":"Cancer Discov"},{"key":"10.1016\/j.ajpath.2025.02.004_bib48","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1164\/rccm.201703-0660OC","article-title":"Blockade of the complement C5a\/C5aR1 axis impairs lung cancer bone metastasis by CXCL16-mediated effects","volume":"197","author":"Ajona","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ajpath.2025.02.004_bib49","doi-asserted-by":"crossref","first-page":"3454","DOI":"10.1158\/0008-5472.CAN-14-0157","article-title":"Complement c5a receptor facilitates cancer metastasis by altering T-cell responses in the metastatic niche","volume":"74","author":"Vadrevu","year":"2014","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2025.02.004_bib50","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.1158\/0008-5472.CAN-11-2996","article-title":"Fibroblast-derived dermal matrix drives development of aggressive cutaneous squamous cell carcinoma in patients with recessive dystrophic epidermolysis bullosa","volume":"72","author":"Ng","year":"2012","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2025.02.004_bib51","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/s41568-019-0238-1","article-title":"A framework for advancing our understanding of cancer-associated fibroblasts","volume":"20","author":"Sahai","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ajpath.2025.02.004_bib52","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13046-019-1515-2","article-title":"C3a-C3aR signaling promotes breast cancer lung metastasis via modulating carcinoma-associated fibroblasts","volume":"39","author":"Shu","year":"2020","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.ajpath.2025.02.004_bib53","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJMoa1805131","article-title":"PD-1 blockade with cemiplimab in advanced cutaneous squamous cell carcinoma","volume":"379","author":"Migden","year":"2018","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"10.1016\/j.ajpath.2025.02.004_bib54","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/jdv.17400","article-title":"Treatment approaches of advanced cutaneous squamous cell carcinoma","volume":"36","author":"Peris","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ajpath.2025.02.004_bib55","article-title":"European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma. Part 2: treatment\u2014update 2023","volume":"193","author":"Stratigos","year":"2023","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ajpath.2025.02.004_bib59","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-007637","article-title":"Efficacy and safety of cosibelimab, an anti-PD-L1 antibody, in metastatic cutaneous squamous cell carcinoma","volume":"11","author":"Clingan","year":"2023","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.ajpath.2025.02.004_bib56","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0140-6736(23)01524-6","article-title":"Complement in human disease: approved and up-and-coming therapeutics","volume":"403","author":"West","year":"2024","journal-title":"Lancet"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944025000732?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944025000732?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T10:38:01Z","timestamp":1747996681000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944025000732"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":57,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S0002944025000732"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpath.2025.02.004","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"C5aR1 Promotes Invasion, Metastasis, and Poor Prognosis in Cutaneous Squamous Cell Carcinoma","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpath.2025.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Society for Investigative Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}